Direct Medical Costs of Advanced Breast Cancer Treatment:A Real-World Study in the Southeast of The Netherlands
OBJECTIVES: Policy makers increasingly seek to complement data from clinical trials with information from routine care. This study aims to provide a detailed account of the hospital resource use and associated costs of patients with advanced breast cancer in The Netherlands. METHODS: Data from 597 patients with advanced breast cancer, diagnosed between 2010 and 2014, were retrieved from the Southeast Netherlands Advanced Breast Cancer Registry. Database lock for this study was in October 2017. We report the observed hospital costs for different resource categories and the lifetime costs per pa... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Schneider , P P , Ramaekers , B L , Pouwels , X , Geurts , S , Ibragimova , K , de Boer , M , Vriens , B , van de Wouw , Y , den Boer , M , Pepels , M , Tjan-Heijnen , V & Joore , M 2021 , ' Direct Medical Costs of Advanced Breast Cancer Treatment : A Real-World Study in the Southeast of The Netherlands ' , Value in Health , vol. 24 , no. 5 , pp. 668-675 . https://doi.org/10.1016/j.jval.2020.12.007 |
Schlagwörter: | BEVACIZUMAB / CARE / ECONOMIC BURDEN / SURVIVAL / The Netherlands / WOMEN / breast neoplasms / healthcare costs / healthcare utilization / real-world data |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26822149 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://cris.maastrichtuniversity.nl/en/publications/d991a017-ad8e-4c80-8fda-edd767ae67c6 |